The COVID-19 vaccine mandate for healthcare workers can take effect nationwide, Supreme Court says
The court lifted injunctions that had halted implementation of the COVID-19 vaccine mandate in half the country, leaving hospitals and other affected providers with likely only a few weeks to begin complying.
How avoiding an awkward waiting room conversation can contribute to better health for transgender people
Listen to the podcast. Societal biases in healthcare not only hurt a provider’s reputation but also the bottom line. When patients don’t feel welcome, they won’t come back until they are sicker and more expensive to care for. On this episode of the Voices in Healthcare Finance podcast, Rodrigo Heng-Lehtinen, executive director of the National…
Coverage denials based on medical necessity are far more likely to arise from Medicare FFS rules than from MA plan policies
Coverage rules stemming from Medicare national and local determinations were the most likely cause of claim denials in one Medicare Advantage plan.
HFMA’s new Premium Facilitated Learning courses combine self-directed study with facilitator feedback and time for peer problem solving
Learn more about HFMA’s Premium Facilitated Learning — a new line of courses — that combine self-directed study with expert facilitation in this Q&A with HFMA’s Sue Spear, director of Digital Learning and Todd Nelson, director of Partner Relationships.
Healthcare labor update: Employment data and research findings underscore ongoing challenges
As highlighted in new employment data and new studies, the healthcare labor market continues to constrain hospitals.
Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders
In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.
No Surprises Act inspires short-term and long-term operational areas of focus
The rush may be over, but the race has just begun. After sprinting to implement the requirements of the No Surprises Act by the Jan. 1, 2022, deadline, providers must now shift attention to refining their processes for what lies ahead. Assuming familiarity with the law’s key requirements, providers and facilities are focused on the…
Healthcare 2030: The Chartis Group and Bank of America discuss embracing disruptors and rethinking care delivery
Melissa McCain, director and leader of the consumer access digital transformation practice of The Chartis Group, and Charles Alston, market executive leader of Bank of America’s healthcare team in the southeastern U.S., discuss HFMA’s Healthcare 2030 series and share insights about what hospitals and health systems should be considering as they plan for the next decade.
Hospital margins increased in November, but labor expenses remained a drag on finances
A skewed labor market continued to affect hospital finances in November even as operating margins improved from October.
New surprise billing regulations: Assessing a patient’s network status will be a key challenge
With new surprise billing regulations in place, providers should seek to implement efficient processes for gauging whether a patient is in-network.